BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27336043)

  • 41. Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins.
    Iwamoto T; Yamada Y; Hori K; Watanabe Y; Sobue K; Inui M
    J Neurochem; 2004 Apr; 89(1):100-8. PubMed ID: 15030393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.
    Ramsey AJ
    Prog Brain Res; 2009; 179():51-8. PubMed ID: 20302817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus.
    Al-Hallaq RA; Conrads TP; Veenstra TD; Wenthold RJ
    J Neurosci; 2007 Aug; 27(31):8334-43. PubMed ID: 17670980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.
    Kristiansen LV; Meador-Woodruff JH
    Schizophr Res; 2005 Oct; 78(1):87-93. PubMed ID: 16023328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.
    Featherstone RE; Shin R; Kogan JH; Liang Y; Matsumoto M; Siegel SJ
    Neurobiol Dis; 2015 Jan; 73():289-95. PubMed ID: 25461194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex.
    Jo K; Derin R; Li M; Bredt DS
    J Neurosci; 1999 Jun; 19(11):4189-99. PubMed ID: 10341223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex.
    Svingos AL; Colago EE
    Brain Res; 2002 Aug; 946(2):262-71. PubMed ID: 12137930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment.
    Iasevoli F; Tomasetti C; Buonaguro EF; de Bartolomeis A
    Curr Neuropharmacol; 2014 May; 12(3):219-38. PubMed ID: 24851087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia.
    de Bartolomeis A; Vellucci L; De Simone G; Mazza B; Barone A; Ciccarelli M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal morphine alters the synaptic complex of postsynaptic density 95 with N-methyl-D-aspartate receptor subunit in hippocampal CA1 subregion of rat offspring leading to long-term cognitive deficits.
    Lin CS; Tao PL; Jong YJ; Chen WF; Yang CH; Huang LT; Chao CF; Yang SN
    Neuroscience; 2009 Feb; 158(4):1326-37. PubMed ID: 19041927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.
    Meador-Woodruff JH; Clinton SM; Beneyto M; McCullumsmith RE
    Ann N Y Acad Sci; 2003 Nov; 1003():75-93. PubMed ID: 14684436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex.
    Gu Z; Jiang Q; Fu AK; Ip NY; Yan Z
    J Neurosci; 2005 May; 25(20):4974-84. PubMed ID: 15901778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating.
    Lin Y; Jover-Mengual T; Wong J; Bennett MV; Zukin RS
    Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19902-7. PubMed ID: 17179037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
    Clinton SM; Haroutunian V; Meador-Woodruff JH
    J Neurochem; 2006 Aug; 98(4):1114-25. PubMed ID: 16762023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M
    Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retention of NMDA receptor NR2 subunits in the lumen of endoplasmic reticulum in targeted NR1 knockout mice.
    Fukaya M; Kato A; Lovett C; Tonegawa S; Watanabe M
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4855-60. PubMed ID: 12676993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of excitatory amino acid neurotoxicity in N-methyl-D-aspartate receptor-deficient mouse cortical neuronal cells.
    Tokita Y; Bessho Y; Masu M; Nakamura K; Nakao K; Katsuki M; Nakanishi S
    Eur J Neurosci; 1996 Jan; 8(1):69-78. PubMed ID: 8713451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95.
    Kornau HC; Schenker LT; Kennedy MB; Seeburg PH
    Science; 1995 Sep; 269(5231):1737-40. PubMed ID: 7569905
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia.
    Tsai SJ; Hong CJ; Cheng CY; Liao DL; Liou YJ
    J Neural Transm (Vienna); 2007; 114(4):423-6. PubMed ID: 17093888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synaptic localization of NMDA receptor subunits in the rat retina.
    Fletcher EL; Hack I; Brandstätter JH; Wässle H
    J Comp Neurol; 2000 Apr; 420(1):98-112. PubMed ID: 10745222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.